CAS NO: | 134-03-2 |
包装 | 价格(元) |
10mM (in 1mL H2O) | 电议 |
1g | 电议 |
Physical Appearance | A solid |
Storage | Store at -20°C |
M.Wt | 198.11 |
Cas No. | 134-03-2 |
Formula | C6H7NaO6 |
Solubility | insoluble in EtOH; insoluble in DMSO; ≥9.1 mg/mL in H2O |
Chemical Name | sodium (R)-2-((S)-1,2-dihydroxyethyl)-4-hydroxy-5-oxo-2,5-dihydrofuran-3-olate |
Canonical SMILES | O=C1C(O)=C([O-])[C@@H]([C@@H](O)CO)O1.[Na+] |
运输条件 | 蓝冰运输或根据您的需求运输。 |
一般建议 | 为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同厂家不同批次产品溶解度各有差异,仅做参考。若实验所需浓度过大至产品溶解极限,请添加助溶剂助溶或自行调整浓度。溶液形式一般不宜长期储存,请尽快用完。 |
Cell experiment:[1] | |
Cell lines | Human glioblastoma multiforme (GBM), rat prostate cancer (PC) and normal mouse 3T3 cells |
Reaction Conditions | 1 ~ 14 mM sodium ascorbate |
Applications | Sodium ascorbate considerably decreased the proliferation and motility of GBM and PC cells. This effect was accompanied by intracellular ROS over-production and necrotic death of tumor cells, apparently resulting from their "autoschizis". |
Animal experiment:[1] | |
Animal models | Male Wistar rats, 200 ~ 230 g |
Dosage form | 1 or 2 mg/kg Injected intravenously at 3rd and 7th day after U87 cell implantation |
Applications | In U87 tumor-bearing rats, intravenous administration of sodium ascorbate inhibited tumor invasionin vivoand seemed to reduce the size of neoplasia. Concomitantly, blood analyses did not show any signs of hemolysis or biochemical disorders after sodium ascorbate administration. High doses of sodium ascorbate were demonstrated to interfere with the expansion of GBM cellsin vitroandin vivo. |
Note | The technical data provided above is for reference only. |
References: 1. Ryszawy D, Pudelek M, Catapano J, et al. High doses of sodium ascorbate interfere with the expansion of glioblastoma multiforme cells in vitro and in vivo. Life Sciences, 2019, 232: 116657. |